+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review

  • ID: 1315546
  • SWOT Analysis
  • December 2019
  • 59 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • ALK-Abello Ltd
  • Biomay AG
  • HAL Allergy BV
  • Laboratorios LETI SL
  • Roxall Medizin GmbH
  • Sanofi UK
  • MORE
Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alternative of aluminium to develop aluminium-free immunotherapy vaccines. Allergy Therapeutics product portfolio includes Pollinex Grasses + Rye and Pollinex Trees vaccines. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise of Pollen, Moulds, Arthropods, Epithelia and others. It has operational presence in Germany, Italy, Spain, Austria, Switzerland, Slovakia, Czech Republic, the Netherlands and the UK. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.

Allergy Therapeutics Plc Key Recent Developments

Sep 25,2019: Allergy Therapeutics announces preliminary results
Jul 11,2019: Allergy Therapeutics provides trading update for the year ended 30 June 2019
Jun 27,2019: Allergy Therapeutics- Trading update and successful litigation settlement
Jun 19,2019: Allergy Therapeutics: Appointment of Mary Tavener as non-executive director
Mar 06,2019: Allergy Therapeutics: Interim results for the six months ended 31 December 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALK-Abello Ltd
  • Biomay AG
  • HAL Allergy BV
  • Laboratorios LETI SL
  • Roxall Medizin GmbH
  • Sanofi UK
  • MORE
Section 1 - About the Company
  • Allergy Therapeutics Plc - Key Facts
  • Allergy Therapeutics Plc - Key Employees
  • Allergy Therapeutics Plc - Key Employee Biographies
  • Allergy Therapeutics Plc - Key Operational Employees
  • Allergy Therapeutics Plc - Major Products and Services
  • Allergy Therapeutics Plc - History
  • Allergy Therapeutics Plc - Company Statement
  • Allergy Therapeutics Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Allergy Therapeutics Plc - Business Description
  • Allergy Therapeutics Plc - Corporate Strategy
  • Allergy Therapeutics Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Allergy Therapeutics Plc - Strengths
  • Allergy Therapeutics Plc - Weaknesses
  • Allergy Therapeutics Plc - Opportunities
  • Allergy Therapeutics Plc - Threats
  • Allergy Therapeutics Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Allergy Therapeutics Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 25, 2019: Allergy Therapeutics announces preliminary results
  • Jul 11, 2019: Allergy Therapeutics provides trading update for the year ended 30 June 2019
  • Jun 27, 2019: Allergy Therapeutics- Trading update and successful litigation settlement
  • Jun 19, 2019: Allergy Therapeutics: Appointment of Mary Tavener as non-executive director
  • Mar 06, 2019: Allergy Therapeutics: Interim results for the six months ended 31 December 2018
  • Jan 16, 2019: Allergy Therapeutics: Trading update & notice of results
  • Nov 27, 2018: Allergy Therapeutics: AGM trading update
  • Nov 08, 2018: Allergy Therapeutics: Director change
  • Sep 26, 2018: Allergy Therapeutics announces preliminary results for the year ended 30 June 2018
  • Jul 12, 2018: Allergy Therapeutics: Trading Update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Allergy Therapeutics Plc, Key Facts
  • Allergy Therapeutics Plc, Key Employees
  • Allergy Therapeutics Plc, Key Employee Biographies
  • Allergy Therapeutics Plc, Key Operational Employees
  • Allergy Therapeutics Plc, Major Products and Services
  • Allergy Therapeutics Plc, History
  • Allergy Therapeutics Plc, Subsidiaries
  • Allergy Therapeutics Plc, Key Competitors
  • Allergy Therapeutics Plc, Ratios based on current share price
  • Allergy Therapeutics Plc, Annual Ratios
  • Allergy Therapeutics Plc, Annual Ratios (Cont...1)
  • Allergy Therapeutics Plc, Annual Ratios (Cont...2)
  • Allergy Therapeutics Plc, Interim Ratios
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Allergy Therapeutics Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Allergy Therapeutics Plc, Performance Chart (2015 - 2019)
  • Allergy Therapeutics Plc, Ratio Charts
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Stallergenes Greer plc
  • Sanofi UK
  • Roxall Medizin GmbH
  • Laboratorios LETI SL
  • HAL Allergy BV
  • Circassia Pharmaceuticals Plc
  • Biomay AG
  • Allergopharma GmbH & Co KG
  • ALK-Abello Ltd
Note: Product cover images may vary from those shown
Adroll
adroll